BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $140,000 | -34.3% | 16,600 | -4.9% | 0.06% | -29.5% |
| Q2 2021 | $213,000 | +0.5% | 17,462 | +99.4% | 0.09% | -2.2% |
| Q1 2021 | $212,000 | -23.2% | 8,756 | +1.8% | 0.09% | -21.7% |
| Q4 2020 | $276,000 | +2.2% | 8,603 | -3.6% | 0.12% | -19.0% |
| Q3 2020 | $270,000 | -36.8% | 8,920 | -12.0% | 0.14% | -29.7% |
| Q2 2020 | $427,000 | – | 10,134 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |